AllRock Bio presents phase 1 data for lead programme, ROC-101 at the ERS Congress: Natick, Massachusetts Tuesday, September 30, 2025, 18:00 Hrs [IST] AllRock Bio, Inc., a clinical ...
Sifting through countless of stocks in the Pharmaceuticals industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about ...
PRINCETON, N.J., Sept. 30, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...
Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, will host an Investor Day today where it will highlight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback